S Dalle, L Thomas… - International journal of …, 2011 - Wiley Online Library Biological response modifiers (BRMs) have dramatically changed therapeutic approaches in dermatology. Pharmacogenomic studies are increasingly integral to the early development phases of targeted therapies. The first evidence supporting the impact that genetic background ... Related articles - All 3 versions
O Hamid, PD Boasberg… - Journal of Surgical …, 2011 - Wiley Online Library ...BIOLOGICALRESPONSEMODIFIERS/INTERLEUKIN-2. ... The proliferation of tumor escape through antigen loss variants of melanoma is an issue that is being overcome through the induction of T-cell response to non-targeted tumor antigens (antigen ... 4 Brem S, Cotran R ...
E Myasoedova, CS Crowson, HM Kremers… - Annals of the …, 2011 - ard.bmj.com ... From the original medical records, we collected data on age, sex, rheumatoid factor (RF) positivity, antirheumatic drugs (methotrexate, hydroxychloroquine, other disease-modifying antirheumatic drugs (DMARDs), biologicalresponsemodifiers and corticosteroids) and statins ... Cited by 3 - Related articles - All 4 versions
HH Bao… - Bioscience, Biotechnology, and Biochemistry, 2011 - J-STAGE ... H. BAO and S. YOU Page 5. ... It has, however, been suggested that the extracts might behave as biologicalresponsemodifiers, stimulating the immune system by the induction of NO or cytokine release which could suppress the growth of cancer cells.10,27) Raw 264.7 murine ... Related articles - All 3 versions
MB Carroll - Expert opinion on biological therapy, 2011 - informahealthcare.com ... It is a pleiotropic cytokine with a diverse array of biological activities and regulates ... a previously stable patient on a biologic response modifier and a nucleot(s)ide analogue ... of HBV reactivation in patients chronically infected with HBV treated with biologic responsemodifiers for a ... Cited by 2 - Related articles - All 4 versions